UMODL1
Uromodulin-like 1
Also known as: UROL1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5DID0
- Gene
- UMODL1
- Ensembl
- ENSG00000177398
- Chromosome
- 21
- Canonical length
- 1318 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable calcium ion binding activity and peptidase inhibitor activity. Predicted to act upstream of or within several processes, including cellular response to gonadotropin-releasing hormone; regulation of granulosa cell apoptotic process; and regulation of ovarian follicle development. Predicted to be located in cytoplasm; external side of plasma membrane; and extracellular region. Predicted to be active in cell surface and extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1318 residues, UniProt reviewed canonical sequence.
>Q5DID0|UMODL1
1 MLRTSGLALL ALVSAVGPSQ ASGFTEKGLS LLGYQLCSHR VTHTVQKVEA VQTSYTSYVS
61 CGGWIPWRRC PKMVYRTQYL VVEVPESRNV TDCCEGYEQL GLYCVLPLNQ SGQFTSRPGA
121 CPAEGPEPST SPCSLDIDCP GLEKCCPWSG GRYCMAPAPQ APERDPVGSW YNVTILVKMD
181 FKELQQVDPR LLNHMRLLHS LVTSALQPMA STVHHLHSAP GNASTTVSRL LLGLPRPLPV
241 ADVSTLLGDI AKRVYEVISV QVQDVNECFY EELNACSGRE LCANLEGSYW CVCHQEAPAT
301 SPRKLNLEWE DCPPVSDYVV LNVTSDSFQV SWRLNSTQNH TFHVRVYRGM ELLRSARTQS
361 QALAVAGLEA GVLYRVKTSY QGCGADVSTT LTIKTNAQVF EVTIKIVNHN LTEKLLNRSS
421 VEYQDFSRQL LHEVESSFPP VVSDLYRSGK LRMQIVSLQA GSVVVRLKLT VQDPGFPMGI
481 STLAPILQPL LASTVFQIDR QGTRVQDWDE CVDSAEHDCS PAAWCINLEG SYTCQCRTTR
541 DATPSRAGRA CEGDLVSPMG GGLSAATGVT VPGLGTGTAA LGLENFTLSP SPGYPQGTPA
601 AGQAWTPEPS PRRGGSNVVG YDRNNTGKGV EQELQGNSIM EPPSWPSPTE DPTGHFLWHA
661 TRSTRETLLN PTWLRNEDSG PSGSVDLPLT STLTALKTPA CVPVSIGRIM VSNVTSTGFH
721 LAWEADLAMD STFQLTLTSM WSPAVVLETW NTSVTLSGLE PGVLHLVEIM AKACGKEGAR
781 AHLKVRTAAR KLIGKVRIKN VRYSESFRNA SSQEYRDFLE LFFRMVRGSL PATMCQHMDA
841 GGVRMEVVSV TNGSIVVEFH LLIIADVDVQ EVSAAFLTAF QTVPLLEVIR GDTFIQDYDE
901 CERKEDDCVP GTSCRNTLGS FTCSCEGGAP DFPVEYSERP CEGDSPGNET WATSPERPLT
961 TAGTKAAFVQ GTSPTPQGLP QRLNLTGAVR VLCEIEKVVV AIQKRFLQQE SIPESSLYLS
1021 HPSCNVSHSN GTHVLLEAGW SECGTLMQSN MTNTVVRTTL RNDLSQEGII HHLKILSPIY
1081 CAFQNDLLTS SGFTLEWGVY TIIEDLHGAG NFVTEMQLFI GDSPIPQNYS VSASDDVRIE
1141 VGLYRQKSNL KVVLTECWAT PSSNARDPIT FSFINNSCPV PNTYTNVIEN GNSNKAQFKL
1201 RIFSFINDSI VYLHCKLRVC MESPGATCKI NCNNFRLLQN SETSATHQMS WGPLIRSEGE
1261 PPHAEAGLGA GYVVLIVVAI FVLVAGTATL LIVRYQRMNG RYNFKIQSNN FSYQVFYELocalizationUniProt · AlphaFold · HPA
Whether an antibody against UMODL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 1 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 1 nTPM
- testis: 0.8 nTPM
- thymus: 0.3 nTPM
- choroid plexus: 0.2 nTPM
- small intestine: 0.2 nTPM
- bone marrow: 0.1 nTPM
Single-cell type
- thymocytes: 79 nCPM
- fallopian tube ciliated cells: 13 nCPM
- early spermatids: 11 nCPM
- late spermatids: 9.6 nCPM
- endometrial ciliated cells: 9.5 nCPM
- renal collecting duct intercalated cells: 9.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 4.1 nTPM
- thalamus: 1.3 nTPM
- amygdala: 1.1 nTPM
- midbrain: 0.9 nTPM
- hippocampal formation: 0.7 nTPM
- hypothalamus: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.32
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adipose tissue development
- cellular response to gonadotropin-releasing hormone
- regulation of gene expression
- regulation of granulosa cell apoptotic process
- regulation of ovarian follicle development
- single fertilization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SEA domain
- EGF-type aspartate/asparagine hydroxylation site
- EGF-like domain
- Zona pellucida domain
- EGF-like calcium-binding domain
- Fibronectin type III
- WAP-type 'four-disulfide core' domain
- Growth factor receptor cysteine-rich domain superfamily
- EMI domain
- Immunoglobulin-like fold
- EGF-like calcium-binding, conserved site
- Fibronectin type III superfamily
- Elafin-like superfamily
- Zona pellucida, ZP-C domain
- Zona pellucida domain, chordate-type
- NOTCH1, EGF-like calcium-binding domain
- ZP-C domain
- ZP-N domain
- WAP-type (Whey Acidic Protein) 'four-disulfide core'
- ZP-C domain
- SEA domain
- Calcium-binding EGF domain
- ZP-N domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UMODL1 as an antibody target. Whether an autoantibody or antibody against UMODL1 could matter depends on whether native UMODL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UMODL1 is annotated at the cell surface, where native UMODL1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label UMODL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...